10.36 USD
+0.07 (+0.68%)
10.36 USD
0 (0%)
Taking everything into account, BODI scores 1 out of 10 in our fundamental rating. BODI was compared to 76 industry peers in the Diversified Consumer Services industry. BODI may be in some trouble as it scores bad on both profitability and health. BODI has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year BODI has reported negative net income.
In the past year BODI had a positive cash flow from operations.
In the past 5 years BODI always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: BODI reported negative operating cash flow in multiple years.
1.2 Ratios
BODI has a Return On Assets of -39.90%. This is in the lower half of the industry: BODI underperforms 76.32% of its industry peers.
The Return On Equity of BODI (-288.76%) is worse than 80.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -39.9% | ||
| ROE | -288.76% | ||
| ROIC | N/A |
ROA(3y)-46.66%
ROA(5y)-36.36%
ROE(3y)-176.86%
ROE(5y)-122.28%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BODI's Gross Margin of 70.02% is amongst the best of the industry. BODI outperforms 84.21% of its industry peers.
In the last couple of years the Gross Margin of BODI has remained more or less at the same level.
BODI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 70.02% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y-1.01%
2. Health
2.1 Basic Checks
BODI does not have a ROIC to compare to the WACC, probably because it is not profitable.
BODI has more shares outstanding than it did 1 year ago.
BODI has less shares outstanding than it did 5 years ago.
BODI has a worse debt/assets ratio than last year.
2.2 Solvency
BODI has an Altman-Z score of -4.59. This is a bad value and indicates that BODI is not financially healthy and even has some risk of bankruptcy.
BODI has a Altman-Z score of -4.59. This is in the lower half of the industry: BODI underperforms 75.00% of its industry peers.
BODI has a Debt/Equity ratio of 1.16. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.16, BODI is doing worse than 65.79% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.16 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -4.59 |
ROIC/WACCN/A
WACC9.63%
2.3 Liquidity
A Current Ratio of 0.60 indicates that BODI may have some problems paying its short term obligations.
BODI's Current ratio of 0.60 is on the low side compared to the rest of the industry. BODI is outperformed by 80.26% of its industry peers.
BODI has a Quick Ratio of 0.60. This is a bad value and indicates that BODI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.48, BODI is not doing good in the industry: 85.53% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.48 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 26.65% over the past year.
Looking at the last year, BODI shows a very negative growth in Revenue. The Revenue has decreased by -20.55% in the last year.
The Revenue for BODI have been decreasing by -11.14% on average. This is quite bad
EPS 1Y (TTM)26.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%164.56%
Revenue 1Y (TTM)-20.55%
Revenue growth 3Y-21.74%
Revenue growth 5Y-11.14%
Sales Q2Q%-41.4%
3.2 Future
The Earnings Per Share is expected to grow by 28.74% on average over the next years. This is a very strong growth
Based on estimates for the next years, BODI will show a decrease in Revenue. The Revenue will decrease by -9.33% on average per year.
EPS Next Y83.66%
EPS Next 2Y39.78%
EPS Next 3Y28.74%
EPS Next 5YN/A
Revenue Next Year-39.63%
Revenue Next 2Y-22.89%
Revenue Next 3Y-9.33%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
BODI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BODI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BODI is valued cheaper than 84.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 5.55 |
4.3 Compensation for Growth
A more expensive valuation may be justified as BODI's earnings are expected to grow with 28.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.78%
EPS Next 3Y28.74%
5. Dividend
5.1 Amount
BODI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
10.36
+0.07 (+0.68%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners40.59%
Inst Owner ChangeN/A
Ins Owners5.22%
Ins Owner Change-1.32%
Market Cap73.45M
Revenue(TTM)418.80M
Net Income(TTM)-58.21M
Analysts80
Price Target10.37 (0.1%)
Short Float %6.64%
Short Ratio0.89
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.74%
Min EPS beat(2)14.53%
Max EPS beat(2)42.94%
EPS beat(4)3
Avg EPS beat(4)7.78%
Min EPS beat(4)-77.42%
Max EPS beat(4)51.05%
EPS beat(8)4
Avg EPS beat(8)-3.9%
EPS beat(12)6
Avg EPS beat(12)-5.4%
EPS beat(16)8
Avg EPS beat(16)-9.68%
Revenue beat(2)2
Avg Revenue beat(2)8.97%
Min Revenue beat(2)7.39%
Max Revenue beat(2)10.54%
Revenue beat(4)3
Avg Revenue beat(4)5.09%
Min Revenue beat(4)-2.88%
Max Revenue beat(4)10.54%
Revenue beat(8)5
Avg Revenue beat(8)3.32%
Revenue beat(12)7
Avg Revenue beat(12)2.29%
Revenue beat(16)9
Avg Revenue beat(16)2.47%
PT rev (1m)31.18%
PT rev (3m)19.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)39.53%
EPS NY rev (3m)39.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)1.7%
Revenue NY rev (3m)1.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.23 | ||
| P/FCF | N/A | ||
| P/OCF | 78.73 | ||
| P/B | 3.64 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.55 |
EPS(TTM)-6.22
EYN/A
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)0.13
OCFY1.27%
SpS45.82
BVpS2.84
TBVpS-7.54
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -39.9% | ||
| ROE | -288.76% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 70.02% | ||
| FCFM | N/A |
ROA(3y)-46.66%
ROA(5y)-36.36%
ROE(3y)-176.86%
ROE(5y)-122.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y-1.01%
F-Score5
Asset Turnover2.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.16 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.83 | ||
| Cap/Depr | 10.93% | ||
| Cap/Sales | 1.26% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 7.32% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.48 | ||
| Altman-Z | -4.59 |
F-Score5
WACC9.63%
ROIC/WACCN/A
Cap/Depr(3y)15.58%
Cap/Depr(5y)44.94%
Cap/Sales(3y)2.05%
Cap/Sales(5y)3.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%164.56%
EPS Next Y83.66%
EPS Next 2Y39.78%
EPS Next 3Y28.74%
EPS Next 5YN/A
Revenue 1Y (TTM)-20.55%
Revenue growth 3Y-21.74%
Revenue growth 5Y-11.14%
Sales Q2Q%-41.4%
Revenue Next Year-39.63%
Revenue Next 2Y-22.89%
Revenue Next 3Y-9.33%
Revenue Next 5YN/A
EBIT growth 1Y61.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year141.63%
EBIT Next 3Y39.5%
EBIT Next 5YN/A
FCF growth 1Y92.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y103.3%
OCF growth 3YN/A
OCF growth 5Y-42.85%
BEACHBODY CO INC/THE / BODI FAQ
What is the ChartMill fundamental rating of BEACHBODY CO INC/THE (BODI) stock?
ChartMill assigns a fundamental rating of 1 / 10 to BODI.
What is the valuation status for BODI stock?
ChartMill assigns a valuation rating of 1 / 10 to BEACHBODY CO INC/THE (BODI). This can be considered as Overvalued.
How profitable is BEACHBODY CO INC/THE (BODI) stock?
BEACHBODY CO INC/THE (BODI) has a profitability rating of 2 / 10.
What is the financial health of BEACHBODY CO INC/THE (BODI) stock?
The financial health rating of BEACHBODY CO INC/THE (BODI) is 0 / 10.
Can you provide the expected EPS growth for BODI stock?
The Earnings per Share (EPS) of BEACHBODY CO INC/THE (BODI) is expected to grow by 83.66% in the next year.